<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Helman G</submitter><funding>NIDA NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>National Health and Medical Research Council</funding><funding>National Institutes of Health</funding><funding>Australian Research Council</funding><pagination>11-19</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8327280</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>121</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>A recurrent homozygous missense variant, c.160G>C;p.(Val54Leu) in HIKESHI, was found to cause a hypomyelinating leukodystrophy with high frequency in the Ashkenazi Jewish population. We provide extended phenotypic classification of this disorder based on clinical history of a further seven affected individuals, assess carrier frequency in the Ashkenazi Jewish population, and provide a neuropathological study.&lt;h4>Methods&lt;/h4>Clinical information, neuroimaging, and biosamples were collected. Brain autopsy was performed for one case.&lt;h4>Results&lt;/h4>Individuals with HIKESHI-related disease share common clinical features: early axial hypotonia evolving to dystonia or with progressive spasticity, hyperreflexia and clonus, feeding difficulties with poor growth, and nystagmus. S</pubmed_abstract><journal>Pediatric neurology</journal><pubmed_title>Further Delineation of the Clinical and Pathologic Features of HIKESHI-Related Hypomyelinating Leukodystrophy.</pubmed_title><pmcid>PMC8327280</pmcid><funding_grant_id>75N95019C00048</funding_grant_id><funding_grant_id>U54 NS115052</funding_grant_id><funding_grant_id>1068278</funding_grant_id><pubmed_authors>Hacker JL</pubmed_authors><pubmed_authors>Ekstein J</pubmed_authors><pubmed_authors>Stutterd CA</pubmed_authors><pubmed_authors>Vanderver A</pubmed_authors><pubmed_authors>Almad A</pubmed_authors><pubmed_authors>Harding B</pubmed_authors><pubmed_authors>Hirsch Y</pubmed_authors><pubmed_authors>Zerem A</pubmed_authors><pubmed_authors>Johansson MM</pubmed_authors><pubmed_authors>Helman G</pubmed_authors><pubmed_authors>Pizzino A</pubmed_authors><pubmed_authors>Viaene AN</pubmed_authors><pubmed_authors>Schmidt JL</pubmed_authors><pubmed_authors>Grinspan JB</pubmed_authors><pubmed_authors>Woidill S</pubmed_authors><pubmed_authors>LeFevre AN</pubmed_authors><pubmed_authors>Taft RJ</pubmed_authors><pubmed_authors>Fattal-Valevski A</pubmed_authors><pubmed_authors>Sase S</pubmed_authors><pubmed_authors>Simons C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Further Delineation of the Clinical and Pathologic Features of HIKESHI-Related Hypomyelinating Leukodystrophy.</name><description>&lt;h4>Background&lt;/h4>A recurrent homozygous missense variant, c.160G>C;p.(Val54Leu) in HIKESHI, was found to cause a hypomyelinating leukodystrophy with high frequency in the Ashkenazi Jewish population. We provide extended phenotypic classification of this disorder based on clinical history of a further seven affected individuals, assess carrier frequency in the Ashkenazi Jewish population, and provide a neuropathological study.&lt;h4>Methods&lt;/h4>Clinical information, neuroimaging, and biosamples were collected. Brain autopsy was performed for one case.&lt;h4>Results&lt;/h4>Individuals with HIKESHI-related disease share common clinical features: early axial hypotonia evolving to dystonia or with progressive spasticity, hyperreflexia and clonus, feeding difficulties with poor growth, and nystagmus. S</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2026-05-08T02:01:21.132Z</modification><creation>2025-02-19T01:31:26.467Z</creation></dates><accession>S-EPMC8327280</accession><cross_references><pubmed>34111619</pubmed><doi>10.1016/j.pediatrneurol.2021.04.014</doi></cross_references></HashMap>